Radiation-Sensitizing Agents
"Radiation-Sensitizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.
| Descriptor ID |
D011838
|
| MeSH Number(s) |
D27.505.954.600
|
| Concept/Terms |
Radiation-Sensitizing Agents- Radiation-Sensitizing Agents
- Radiation Sensitizers
- Sensitizers, Radiation
- Radiation Sensitizing Agents
- Sensitizing Agents, Radiation
- Radiosensitizing Agents
- Agents, Radiosensitizing
- Radiosensitizing Drugs
- Drugs, Radiosensitizing
- Agents, Radiation-Sensitizing
- Agents, Radiation Sensitizing
- Radiation-Sensitizing Drugs
- Drugs, Radiation-Sensitizing
- Radiation Sensitizing Drugs
Radiation-Sensitizing Effect- Radiation-Sensitizing Effect
- Effect, Radiation-Sensitizing
- Radiation Sensitizing Effect
- Radiosensitizing Effect
- Effect, Radiosensitizing
- Radiosensitizing Effects
- Effects, Radiosensitizing
- Radiation-Sensitizing Effects
- Effects, Radiation-Sensitizing
- Radiation Sensitizing Effects
|
Below are MeSH descriptors whose meaning is more general than "Radiation-Sensitizing Agents".
Below are MeSH descriptors whose meaning is more specific than "Radiation-Sensitizing Agents".
This graph shows the total number of publications written about "Radiation-Sensitizing Agents" by people in this website by year, and whether "Radiation-Sensitizing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 4 | 2 | 6 |
| 2019 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Radiation-Sensitizing Agents" by people in Profiles.
-
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines. Cancer Lett. 2019 Oct 01; 461:90-101.
-
Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck. J Natl Cancer Inst. 2019 05 01; 111(5):490-497.
-
Deregulated MicroRNA Signature Following Glioblastoma Irradiation. Cancer Control. 2019 Jan-Dec; 26(1):1073274819847226.
-
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. Crit Rev Oncol Hematol. 2019 Feb; 134:87-103.
-
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity. Crit Rev Oncol Hematol. 2019 Feb; 134:104-119.
-
Exploring the Role of Enzalutamide in Combination with Radiation Therapy: An In Vitro Study. Anticancer Res. 2018 Jun; 38(6):3487-3492.
-
Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide. Oncogene. 2018 09; 37(39):5292-5304.
-
Radiosensitization of clioquinol and zinc in human cancer cell lines. BMC Cancer. 2018 04 20; 18(1):448.
-
Stable black phosphorus/Bi2O3 heterostructures for synergistic cancer radiotherapy. Biomaterials. 2018 07; 171:12-22.
-
The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines. Neuroscience. 2017 03 27; 346:298-308.